Yonghe Medical Group Co., Ltd.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. carries a market capitalization of 815.18M, placing it among publicly traded companies globally. Its enterprise value stands at 520.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Yonghe Medical Group Co., Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. has 500.11M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Yonghe Medical Group Co., Ltd.'s stock has gained approximately 2.21% over the past 52 weeks. The 50-day moving average sits at 2.15, while the 200-day moving average is 2.04.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. holds 833.75M in cash and equivalents against 539.39M in total debt, resulting in a net debt position of -777.90M. Total book value stands at 877.02M, with working capital of 338.54M providing operational flexibility.